These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 577507)

  • 41. Relative bioavailability of two isosorbide dinitrate sublingual tablet formulations administered as single doses in healthy subjects.
    Niopas I; Daftsios AC; Nikolaidis N
    Int J Clin Pharmacol Ther; 2001 May; 39(5):224-8. PubMed ID: 11380069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic profile of a new controlled-release isosorbide-5-mononitrate 60 mg scored tablet (Monoket Multitab).
    Stockis A; De Bruyn S; Deroubaix X; Jeanbaptiste B; Lebacq E; Nollevaux F; Poli G; Acerbi D
    Eur J Pharm Biopharm; 2002 Jan; 53(1):49-56. PubMed ID: 11777752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma levels of isosorbide dinitrate and the isosorbide mononitrates after increasing doses of a retard preparation of isosorbide dinitrate.
    Bogaert MG; Rosseel MT
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2424-7. PubMed ID: 7422532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pharmacokinetic model for isosorbidedinitrate, isosorbide-2-mononitrate, and isosorbide-5-mononitrate.
    Smith D; Aldrich W; Dey M; Enever R; Warner R; Weierstall R
    Drug Metab Dispos; 1990; 18(4):429-34. PubMed ID: 1976063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma levels of isosorbide dinitrate and its main metabolites following oral administration of two sustained release formulations in normal man.
    Gladigau V; Neurath G; Dünger M; Schnelle K; Johnson KI
    Arzneimittelforschung; 1981; 31(5):835-40. PubMed ID: 7196746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
    Geigenberger A; Degen J; Maier-Lenz H
    Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of isosorbide dinitrate and its mononitrate metabolites after intravenous infusion.
    Santoni Y; Iliadis A; Cano JP; Luccioni R; Frances Y
    J Pharmacokinet Biopharm; 1986 Feb; 14(1):1-17. PubMed ID: 3746630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate.
    Hirayama F; Hirashima N; Abe K; Uekama K; Ijitsu T; Ueno M
    J Pharm Sci; 1988 Mar; 77(3):233-6. PubMed ID: 3373427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Study of the bioequivalence of a new isosorbide dinitrate tablet formulation compared with the standard preparation].
    Metzner JE; Buchberger D; Häring N; Läuter J
    Arzneimittelforschung; 1997 Jun; 47(6):719-26. PubMed ID: 9281301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A combined single and multiple dose pharmacokinetic study of oral isosorbide-5-mononitrate in healthy volunteers.
    Storm G; Oosterhuis B; Bron J; Wittebrood AJ; De Jong AP; Jonkman JH
    Biopharm Drug Dispos; 1991 Dec; 12(9):661-72. PubMed ID: 1790311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioavailability and pharmacokinetics of a new isosorbide dinitrate spray preparation in healthy volunteers.
    Hutt V; Theodor R; Pabst G; Lutz D; Bonn R; Fritschi E
    Arzneimittelforschung; 1993 Aug; 43(8):842-6. PubMed ID: 8216439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Finger pulse plethysmographic effects of two oral sustained-release formulations of isosorbide dinitrate in normal man.
    Schnelle K; Fenzl E; Johnson KI; Gladigau V; Schinz A
    Arzneimittelforschung; 1981; 31(5):840-3. PubMed ID: 7196747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of isosorbide mononitrate in a new sustained release oral form in comparison with a conventional formulation.
    Gandini R; Cunietti E; Assereto R; Castoldi D; Tofanetti O; Baggio E
    Arzneimittelforschung; 1987 Jul; 37(7):836-9. PubMed ID: 3675680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemodynamic effects of isosorbide dinitrate vs nitroglycerin in patients with unstable angina.
    Willis WH; Russell RO; Mantle JA; Ratshin RA; Rackley CE
    Chest; 1976 Jan; 69(1):15-22. PubMed ID: 811427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of intravenous isosorbide-dinitrate.
    Platzer R; Reutemann G; Galeazzi RL
    J Pharmacokinet Biopharm; 1982 Dec; 10(6):575-86. PubMed ID: 7182455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A study into the mucosal absorption of isosorbide dinitrate at different intraoral sites.
    Pimlott SJ; Addy M
    Oral Surg Oral Med Oral Pathol; 1985 Feb; 59(2):145-8. PubMed ID: 3856798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of isosorbide dinitrate spray on central hemodynamics. Comparison with sublingual glyceryl trinitrate and isosorbide dinitrate.
    Saito M; Fukami K; Sumiyoshi T; Haze K; Hiramori K
    Arzneimittelforschung; 1984; 34(6):707-9. PubMed ID: 6435644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved method for the rapid determination of isosorbide dinitrate in human plasma and its application in pharmacokinetic studies.
    Laufen H; Scharpf F; Bartsch G
    J Chromatogr; 1978 Nov; 146(3):457-64. PubMed ID: 721922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electron-capture GLC determination of nanogram to picogram amounts of isosorbide dinitrate.
    Malbica JO; Monson K; Neilson K; Sprissler R
    J Pharm Sci; 1977 Mar; 66(3):384-6. PubMed ID: 845805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
    Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
    Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.